LIVEMarkets rolling coverageStarted: July 23, 2026, 4:00 AM EDTUpdated: July 23, 2026, 6:23 AM EDT Thalia Therapeutics Issues 200 Million Share Options to Five Directors Conditional on Price Milestones July 23, 2026, 6:23 AM EDT. Thalia Therapeutics has awarded options on 200 million ordinary shares to five members of its board through a share option scheme. The grants are linked to share price performance targets, representing a major governance development reported by the company. Thalia Therapeutics Grants Major Director Option Package Tied to Share Price Targets Nasdaq, S&P 500 Futures Slip on Tesla and Alphabet’s Expanding AI Costs July 23,